Improved solubility of docetaxel using a microemulsion delivery system: Formulation optimization and evaluation

Asian Journal of Pharmaceutical Sciences

Volumn 4, Issue 6, 2009, Pages 331-339

  Yin, Yongmei ^a,b   Cui, Fude ^a   Mu, Chaofeng ^a,b   Chung, Suk Jae ^b   Shim, Chang Koo ^b   Kim, Dae Duk ^b  

^a SHENYANG PHARMACEUTICAL UNIVERSITY   (China)

^b Seoul National University   (South Korea)

Author keywords

Docetaxel; Microemulsion; Solubility

Indexed keywords

DOCETAXEL;

ANIMAL EXPERIMENT; ANIMAL MODEL; AREA UNDER THE CURVE; ARTICLE; BREAST CANCER; CANCER CELL CULTURE; CONTROLLED STUDY; CYTOTOXICITY; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG SCREENING; DRUG SOLUBILITY; ELECTROPHORESIS; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MALE; MICROEMULSION; NONHUMAN; SPRAGUE DAWLEY RAT;

EID: 77953447474     PISSN: 18180876     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. K. A. Lyseng-Williamson, C. Fenton. Docetaxel: a review of its use in metastatic breast cancer. Drugs, 2005, 65: 2513-2531.
2. S. J. Clarke, L. P. Rivory. Clinical pharmacokinetics of docetaxel. Clin Pharmacokinet., 1999, 36: 99-114.
3. M. C. Bissery. Preclinical pharmacology of docetaxel. Eur. J. Cancer, 1995, 31: S1-S6.
4. U. Vanhoefer, S. Cao, A. Harstrick, et al. Comparative antitumor efficacy of docetaxel and paclitaxel in nude mice bearing human tumor xenografts that over-express the multidrug resistance protein (MRP). Ann. Oncol., 1997, 8: 1221-1228.
5. A. M. Mac Connachie. Docetaxel (Taxotere, Rhone-Poulenc Rorer). Intensive Crit. Care Nurs., 1997, 13: 119-120.
6. E. K. Rowinsky. The development and clinical utility of the taxane class of antimicrotubule chemotherapy agents. Annu. Rev. Med., 1997, 48: 353-374.
7. R. B. Weiss, R. C. Donehower, P. H. Wiernik, et al. Hypersensitivity reactions from Taxol. J. Clin. Oncol., 1990, 8: 1263-1268.
8. X. L. Zhao, D. W. Chen, P. Gao, et al. Synthesis of ibuprofen eugenol ester and its microemulsion formulation for parenteral delivery. Chem. Pharm. Bull., 2005, 53: 1246-1250.
9. K. M. Park, C. K. Kim. Preparation and evaluation of flurbiprofen-loaded microemulsion for parenteral delivery. Int. J. Pharm., 1999, 181: 173-179.
10. C. Von Corswant, P. Thorén, S. Engström. Triglyceride-based microemulsion for intravenous administration of sparingly soluble substances. J. Pharm. Sci., 1998, 87: 200-208.
11. J. M. Lee, K. M. Park, S. J. Lim, et al. Microemulsion formulation of clonixic acid: solubility enhancement and pain reduction. J. Pharm. Pharmacol., 2002, 54: 43-44.
12. I. F. Uchegbu. The biodistribution of novel 200-nm palmitoyl muramic acid vesicles. Int. J. Pharm., 1998, 162: 19-27.
13. A. Sharma, U. S. Sharma, R. M. Straubinger. Paclitaxel-liposomes for intracavity therapy of intraperitoneal P388 leukemia. Cancer Lett., 1996, 107: 265-272.
14. J. Ciccolini, J. Catalin, M. F. Blachon, et al. Rapid high-performance liquid chromatographic determination of docetaxel (Taxotere) in plasma using liquid-liquid extraction. J. Chromatogr. B Biomed. Sci. Appl., 2001, 759: 299-306.
15. M. J. Lawrence, G. D. Rees. Microemulsion-based media as novel drug delivery systems. Adv. Drug Deliv. Rev., 2000, 45: 89-121.
16. A. S. Narang, D. Delmarre, D. Gao. Stable drug encapsulation in micelles and microemulsions. Int. J. Pharm., 2007, 342: 9-25.
17. L. Feng, L. Dexi. Long-circulating emulsions (oil-in-water) as carriers for lipophilic drugs. Pharm. Res., 1995, 12: 1060-1064.